Accelerating HCP engagement in Singapore using customer reference data
C-Tech Analytical Solutions
C-Tech Analytical Solutions
C-Tech Analytical Solutions
C-Tech Analytical Solutions
C-Tech Analytical Solutions
C-Tech Analytical Solutions
C-Tech Analytical Solutions
C-Tech Analytical Solutions
C-Tech Analytical Solutions
Get a free Nalgene bottle when you send us an enquiry!
Get a free Nalgene bottle when you send us an enquiry!
Get a free Nalgene bottle when you send us an enquiry!
Get a free Nalgene bottle when you send us an enquiry!
Get a free Nalgene bottle when you send us an enquiry!
Get a free Nalgene bottle when you send us an enquiry!
Get a free Nalgene bottle when you send us an enquiry!

Pharma News

Looking out for latest news on Pharma Magazine?
Check out the latest Pharma news, Top news in Pharma Magazine, Leading Magazine in Pharma industry. Daily news updates pertinent to the industrial sectors we are engaged with are depicted on the news section of Pharma industry which we operate.

AstraZeneca and Oncoshot establish strategic partnership to better streamline recruitment process for cancer clinical trials

Friday, September 24, 2021

Amnio Technology LLC a global leader in the development and distribution of amniotic tissue allografts is announcing today that the United States Patent and Trademark Office has issued a new patent titled Enriched Multilayer Amnion Derived Tissue Gra...

Phenomenex Announces the Release of New Biozen® SEC Size Exclusion Chromatography Columns

Friday, September 24, 2021

Phenomenex Inc a global leader in the research and manufacture of advanced technologies for the separation sciences announces the successful launch of NEW Biozen SEC Size Exclusion Chromatography Columns to the existing Biozen portfolio of biological...

Pfizer and BioNTech Receive First U.S. FDA Emergency Use Authorization of a COVID-19 Vaccine Booster

Thursday, September 23, 2021

Pfizer Inc and BioNTech SE announced that the US Food and Drug Administration FDA has authorized for emergency use a booster dose of the PfizerBioNTech COVID Vaccine for individuals years of age and older individuals through years of age at high r...

AbCellera and Everest Medicines Announce Multi-Target Collaboration to Advance New Antibody Therapies

Thursday, September 23, 2021

AbCellera and Everest Medicines Limited announced that they have entered into a multiyear collaboration and license agreement to discover therapeutic antibodies for up to targets selected by Everest The partnership will help to expand Everests portf...

Persephone Biosciences Inc. Announces Collaboration with Janssen Biotech, Inc.

Wednesday, September 22, 2021

Persephone Biosciences Inc a privately held datadriven microbiomefocused biotechnology company today announced that it has entered into a collaboration agreement with Janssen Biotech Inc Janssen one of the Janssen Pharmaceutical Companies of Johnson...

FDA Approves LEXETTE (R) for Adolescent Plaque Psoriasis

Wednesday, September 22, 2021

Mayne Pharma is pleased to announce that the US Food and Drug Administration FDA has approved LEXETTE halobetasol propionate foam for use in adolescents LEXETTE a super potent topical corticosteroid is now approved for the treatment of plaque psoria...

Boehringer Ingelheim and Oxford BioTherapeutics Partnership Advances Second Oncology Drug Candidate into the Clinic

Tuesday, September 21, 2021

Oxford BioTherapeutics OBT a clinical stage oncology company with a pipeline of immunooncology and ADCbased therapies today announced that it has received another milestone payment from Boehringer Ingelheim BI for the progress of a second oncology dr...

Hikma and FAES Farma enter into exclusive licensing agreement for the commercialisation of Bilastine tablets in the US

Tuesday, September 21, 2021

Hikma Pharmaceuticals PLC Hikma the multinational generic pharmaceutical company announces the signing of an exclusive US license agreement with FAES Farma SA to commercialise Bilastine tablets a nonsedating second generation antihistamine molecule f...

PerkinElmer Completes Acquisition of Antibody and Reagent Leader BioLegend

Monday, September 20, 2021

PerkinElmer Inc a global leader committed to innovating for a healthier world today announced it has completed its acquisition of BioLegend a leading worldwide provider of life science antibodies and reagents for a total consideration of approximatel...

Resonant Therapeutics Announces Advancement in Collaboration With Janssen

Friday, September 17, 2021

Resonant Therapeutics Inc a biotechnology company focused on cancer therapeutic discovery based on unique insights into the tumor microenvironment today announced that the company has advanced into the next phase of its ongoing agreement with Janssen...

Latest Issue
Get instant
access to our latest e-book
Rousselot || X-Pure® GelMA Meco - 90 years Medical Fair Thailand 2022